Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
FDA STANDARD OF +/-20% ADEQUATE TO ASSURE BIOEQUIVALENCE OF GENERICS, TASK FORCE MAINTAINS; +/-10% CRITERIA HAS "SOME MERIT" AS EXTRA ASSURANCE
Feb 15 1988
Â
•Â
ByÂ
The Pink Sheet
 Â
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Archive
More from Pink Sheet